Synokem Pharmaceutical Gets CDSCO Panel Nod To study Antidiabetic FDC Drug Dr. Divya Colin21 Dec 2023 6:00 PM ISTNew Delhi: With the condition of including more government sites distributed geographically, Synokem Pharmaceutical has got approval from the Subject...
Modify phase III clinical trial protocol: CDSCO panel tells Akum Pharma on antidiabetic FDCÂ Dr. Divya Colin17 Dec 2023 5:30 PM ISTNew Delhi: Approving to conduct the bioequivalence (BE) study of the antidiabetic drug combination Repaglinide plus Voglibose plus Metformin...
Abbott Gets CDSCO Panel Nod To Study Antidiabetic FDC Dapagliflozin plus Metformin Dr. Divya Colin21 Oct 2023 7:00 PM ISTNew Delhi: The drug major Abbott Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin2 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit BE study, Phase III trial protocol: CDSCO panel tells Glenmark on Metformin, Glimepiride, Lobeglitazon FDC Susmita Roy1 Oct 2023 6:00 PM ISTNew Delhi: Citing the proposed fixed-dose combination (FDC) is not approved internationally, the Subject Expert Committee (SEC) functional under the...
Sun Pharma Gets CDSCO Panel Nod To Market Sitagliptin, Metformin, Glimepiride FDC in Lower Strength Dr. Divya Colin30 Sept 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
USV Launches Liralin Range for Diverse Group of Type 2 Diabetes Patients MD Brand Connect4 Sept 2023 1:55 PM ISTUSV Pvt. Ltd, a leading drug manufacturer in the diabetes & cardiology segment, has announced the launch of the Liralin Range for the treatment...
Synokem Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug Sitagliptin plus Empagliflozin Dr. Divya Colin3 Sept 2023 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma Gets CDSCO panel Nod To Manufacture, Market Sitagliptin, Metformin, Glimepiride antidiabetic FDC Dr. Divya Colin1 Sept 2023 6:00 PM ISTNew Delhi: Based on the Phase III clinical trial report and bioequivalence (BE) study report of the antidiabetic fixed-dose combination (FDC) drug...
Synokem Gets CDSCO Panel Nod To Manufacture, Market antidiabetic FDC Pioglitazone, Vildagliptin Dr. Divya Colin31 Aug 2023 6:00 PM ISTNew Delhi: With the condition of conducting phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma Gets CDSCO Panel Nod to Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin30 Aug 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Akums Pharma Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin9 July 2023 6:00 PM ISTNew Delhi: Noting that the antidiabetic fixed-dose combination (FDC), Sitagliptin Phosphate Monohydrate 100mg/100mg plus Pioglitazone 15mg/15mg plus...
